VCs sell stakes in Kandy Therapeutics to Bayer
Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners, OrbiMed and Longitude Capital have sold their stakes in menopause therapy developer Kandy Therapeutics to Bayer's women's health division.